ArticleInfection and drug resistance2023

Ruxolitinib as an Effective Treatment for Hemophagocytic Lymphohistiocytosis Secondary to SARS-Cov-2 Infection: A Case Report.

Lina Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.